Liver X receptor agonist T0901317 inhibits the migration and invasion of non-small-cell lung cancer cells in vivo and in vitro-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Liver X receptor agonist T0901317 inhibits the migration and invasion of non-small-cell lung cancer cells in vivo and in vitro

Published:2019-06 Issue:5 Volume:30 Page:495-500
ISSN:0959-4973
Container-title:Anti-Cancer Drugs
language:en
Short-container-title:

Author:

Lou Rui,Cao Haixia,Dong Shuchen,Shi Chen,Xu Xiaoyue,Ma Rong,Wu Jianzhong,Feng Jifeng

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology (medical),Pharmacology,Oncology

Reference26 articles.

1. Analysis of lncRNA expression profiles in non-small cell lung cancers (NSCLC) and their clinical subtypes;Yang;Lung Cancer,2014

2. EGFR-TKI resistance in NSCLC patients: mechanisms and strategies;Lin;Am J Cancer Res,2014

3. Epidermal growth factor receptor (EGFR) mutation and personalized therapy in advanced nonsmall cell lung cancer (NSCLC);Kobayashi;Target Oncol,2013

4. EGFR and KRAS mutations, and ALK fusions: current developments and personalized therapies for patients with advanced non-small-cell lung cancer;de Mello;Pharmacogenomics,2013

5. Molecular spectrum of somatic EGFR and KRAS gene mutations in non small cell lung carcinoma: determination of frequency, distribution pattern and identification of novel variations in Indian patients;Das;Pathol Oncol Res,2015

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ergosterol and its metabolites as agonists of Liver X receptor and their anticancer potential in colorectal cancer;The Journal of Steroid Biochemistry and Molecular Biology;2024-10

2. Targeting Liver X Receptors in Cancer Drug Discovery;Receptors;2024-06-29

3. Liver X Receptors (LXRs) in cancer-an Eagle’s view on molecular insights and therapeutic opportunities;Frontiers in Cell and Developmental Biology;2024-03-14

4. The cell line models to study tyrosine kinase inhibitors in non-small cell lung cancer with mutations in the epidermal growth factor receptor: A scoping review;Critical Reviews in Oncology/Hematology;2024-02

5. Cholesterol metabolism in tumor microenvironment: cancer hallmarks and therapeutic opportunities;International Journal of Biological Sciences;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3